Computationally repurposing drugs for breast cancer subtypes using a network-based approach
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Computationally repurposing drugs for breast cancer subtypes using a network-based approach ; volume:23 ; number:1 ; day:20 ; month:4 ; year:2022 ; pages:1-36 ; date:12.2022
BMC bioinformatics ; 23, Heft 1 (20.4.2022), 1-36, 12.2022
- Urheber
-
Firoozbakht, Forough
Rezaeian, Iman
Rueda, Luis
Ngom, Alioune
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-022-04662-6
- URN
-
urn:nbn:de:101:1-2022070308163683907915
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Firoozbakht, Forough
- Rezaeian, Iman
- Rueda, Luis
- Ngom, Alioune
- SpringerLink (Online service)
Ähnliche Objekte (12)
Network-based drug repurposing for schizophrenia
Drug repurposing
Network-based approach to prediction and population-based validation of in silico drug repurposing
Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing
Drug repurposing in cardiology
Drug Repurposing in Oncology
Repurposing of approved cardiovascular drugs
Drug repurposing for cancer therapy
Drug repurposing with network reinforcement
Genomic strategies for drug repurposing
Drug Repurposing through Network Medicine
Network-based drug sensitivity prediction
Network-based drug repurposing for schizophrenia
Drug repurposing
Network-based approach to prediction and population-based validation of in silico drug repurposing
Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing
Drug repurposing in cardiology
Drug Repurposing in Oncology
Repurposing of approved cardiovascular drugs
Drug repurposing for cancer therapy
Drug repurposing with network reinforcement
Genomic strategies for drug repurposing
Drug Repurposing through Network Medicine
Network-based drug sensitivity prediction
Network-based drug repurposing for schizophrenia
Drug repurposing
Network-based approach to prediction and population-based validation of in silico drug repurposing
Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing
Drug repurposing in cardiology
Drug Repurposing in Oncology
Repurposing of approved cardiovascular drugs
Drug repurposing for cancer therapy
Drug repurposing with network reinforcement
Genomic strategies for drug repurposing
Drug Repurposing through Network Medicine